Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments
NCT02662868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 767
Last updated 2017-02-23
Summary
The purpose of this study is to describe demographics and socioeconomics characteristics associated to the diagnosis of metastatic breast cancer in Brazil.
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
-
Latin American Cooperative Oncology Group
lead OTHER
Principal Investigators
-
Gustavo Werutsky, MD · Latin American Cooperative Oncology Group
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2016-06-30
- Completion
- 2016-12-31
Countries
- Brazil
Study Locations
More Related Trials
-
A Prospective Cohort With Patient Navigation as an Intervention for Breast Cancer Patients
NCT06257888 ·Status: COMPLETED
-
Brain Metastasis Development Mechanism in BCBM Patients
NCT06330870 ·Status: RECRUITING ·Phase: NA
-
Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer
NCT02670668 ·Status: UNKNOWN ·Phase: NA
-
A Retrospective Study of Prognostic Factors and Survival of Breast Cancer Patients with Brain Metastesis
NCT06723132 ·Status: NOT_YET_RECRUITING
-
Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma
NCT04365790 ·Status: UNKNOWN
-
Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy
NCT01198301 ·Status: COMPLETED
-
The Use of Metformin in Early Breast Cancer Patients Pre-Surgery
NCT01302002 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy
NCT05665920 ·Status: RECRUITING ·Phase: NA
-
Correlation Between Circulating Tumor Cells and Brain Disease Control After Focal Radiotherapy for Metastases of Breast Cancer
NCT02941536 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer
NCT01460186 ·Status: COMPLETED ·Phase: NA
-
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
NCT06698679 ·Status: RECRUITING
-
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
NCT06055881 ·Status: RECRUITING ·Phase: NA
-
Study in Patients With Breast Cancer Leptomeningeal Metastasis
NCT06638294 ·Status: RECRUITING
-
Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer
NCT06358625 ·Status: RECRUITING
-
Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer.
NCT07056205 ·Status: ENROLLING_BY_INVITATION
-
Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer
NCT01282931 ·Status: COMPLETED
-
Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer
NCT06790264 ·Status: RECRUITING ·Phase: NA
-
Τreatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer
NCT04247035 ·Status: UNKNOWN
-
Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes
NCT04403984 ·Status: UNKNOWN
-
A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases
NCT06544668 ·Status: NOT_YET_RECRUITING
-
Serum Retinoic Acid Induced Protein 14 (RAI14) and Metastasis Associated Cancer Colon -1 (MACC-1) in Breast Cancer
NCT06097546 ·Status: NOT_YET_RECRUITING
-
Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic Mutation
NCT04368442 ·Status: UNKNOWN
-
A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China
NCT06591039 ·Status: RECRUITING
-
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer
NCT06001528 ·Status: RECRUITING